cannabis business for a whopping £5.3billion. Geoffrey Guy got the nickname after his drugs company GW Pharmaceuticals started using cannabis to develop medicines in the US.
He founded the firm in 1998 and is now celebrating his windfall after it was snapped up by Irish peer Jazz Pharmaceuticals. The deal said to be worth $7.2bn, the Mirror reports.
It was revealed yesterday with an announcement to shareholders in the New York-listed GW.Following the news it was approved unanimously by directors on both boards, and will see Jazz pay 200 dollars per share in cash, as well as 20 dollars in its own shares.GW is known for developing medicines from cannabis.
Read more on dailystar.co.uk